Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal int...

Full description

Bibliographic Details
Main Authors: Romain Daillère, Lisa Derosa, Mélodie Bonvalet, Nicola Segata, Bertrand Routy, Manuela Gariboldi, Eva Budinská, I. Jolanda M. De Vries, Alessio Gordon Naccarati, Valérie Zitvogel, Carlos Caldas, Lars Engstrand, Sibylle Loilbl, Jacques Fieschi, Lucie Heinzerling, Guido Kroemer, Laurence Zitvogel
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
gut microbiota
anticancer therapeutics
clinical trials
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1774298

Internet

http://dx.doi.org/10.1080/2162402X.2020.1774298

Similar Items